SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010

Int J Gynaecol Obstet. 2011 Mar;112(3):252-6. doi: 10.1016/j.ijgo.2010.12.003.

Abstract

Objective: To provide current and emerging evidence on oral contraceptives and the risk of venous thromboembolism.

Evidence: Articles published in English from 2005 were retrieved through searches of PubMed and Medline, using the following terms: venous thromboembolism, VTE, contraception, oral contraceptives, hormonal contraception. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. Searches were updated on a regular basis and incorporated in the guideline to May 2010. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.

Values: The quality of evidence was rated using the criteria described by the Canadian Task Force on Preventive Health Care (Table).

Publication types

  • Practice Guideline

MeSH terms

  • Canada
  • Contraceptives, Oral / adverse effects*
  • Female
  • Humans
  • Risk Factors
  • Venous Thromboembolism / chemically induced*

Substances

  • Contraceptives, Oral